Navigation Links
Effect of Maternal Diet on Colic Among Breastfed Infants

Recent research suggests that maternal intake of food allergens is an important factor in the pathogenesis of infantile colic among breastfed infants.

Infantile colic affects up to 28% of infants in the first months of life//. Colic symptoms usually peak at 6 weeks of age and improve gradually over the following weeks. In the study, which appears in the current issue of the journal Pediatrics, a randomized, controlled trial of a low-allergen maternal diet was conducted among exclusively breastfed infants presenting with colic.

In the test group, mothers excluded cow's milk, eggs, peanuts, tree nuts, wheat, soy, and fish from their diet; mothers in the control group continued to consume these foods.

The mothers first recorded how often their babies cried or fussed on days one and two of the study. Then each group of mothers started its diet regimens for a week. The mothers recorded their babies' crying and fussing again on days eight and nine.

Outcomes were assessed after 7 days, as the change in cry/fuss duration over 48 hours, with validated charts. The primary end point was a reduction in cry/fuss duration of 25% from baseline. Mothers also assessed the responses to diet with categorical and visual analog scales.

At the end of the study, 74% of infants in the low-allergen group experienced at least a 25% reduction in crying and fussing. Only 37% of infants in the standard-diet group had a similar reduction. "These findings suggest that maternal intake of food allergens is an important factor in the [development] of infantile colic among breastfed infants," the researchers write.

Exclusion of allergenic foods from the maternal diet was thus found to be associated with a reduction in distressed behavior among breastfed infants with colic presenting in the first 6 weeks of life.

This study suggests that study shows breastfeeding moms should consider avoiding allergenic foods.

However, the re searchers wars that breastfeeding mothers should not make drastic diet changes on their own, as elimination diets have associated risks, particularly if sustained for long periods. They suggest additional studies to define the pathophysiologic features and role of maternal elimination diets in infantile colic.
'"/>




Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Inhaled Steroids Safe & Effective for Children with Asthma
3. Acupuncture May Help Chemotherapy Side Effects
4. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
5. Fluoride Found Effective in Osteoporosis
6. Aspirin and Warfarin Are Equally Effective for Stroke Prevention
7. Implantable Contact Lens Found Safe and Effective
8. Effective And Economical Agent For Anthrax
9. Stem Cell Transplants May Be Effective For MS Patients
10. Chemotherapy Pill Has Fewer Side Effects Than IV
11. Effect of Osteosarcoma predicted by scans
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: